Gene analysis results from 348 HR-positive HER2-negative metastatic BC samples showed that loss of FAT1, a tumor suppressor belonging to chaderin family involved in upregulation of CDK6 expression via Hippo pathway, is associated with a shorter PFS, suggesting its possible role as predictor of CDK4/6i resistance [136]. The gene discussed is ERBB2; the disease is neoplasm.